Alterna Wealth Management, Inc Eli Lilly & CO Transaction History

Alterna Wealth Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $205,857 - $247,747	-1,509 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $179,646 - $222,351	1,509 New	1,509 $209,000
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $201,116 - $249,100	-1,881 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $783,091 - $851,801	-7,333 Reduced 79.59%	1,881 $210,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $975,762 - $1.09 Million	9,214 New	9,214 $758,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Alterna Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Alterna Wealth Management, Inc with notifications on news.